Wei Pei

Introduction

Wei Pei has been practising law since 2008, mainly specialising in corporate restructuring, IPOs, refinancing, M&A and restructuring of listed companies, industrial integration, PE/VC, and foreign direct investment. He has provided professional legal services to a wide range of enterprises across industries including finance, manufacturing, high-tech, telecoms, agriculture, gene sequencing, medical devices, e-commerce and internet services, covering both domestic and overseas equity offerings and listings, cross-border and domestic M&A, mergers and restructurings of state-owned enterprises, debt-to-equity swaps, and other complex transactions, and has accumulated extensive professional experience in the process.

Representative deals include:

• MGI Tech – IPO on the Star Market (A-share);
• CALB – H-share IPO;
• Dekon Food and Agriculture Group – H-share IPO;
• Cirrus Aircraft – Red-chip IPO;
• CGN New Energy Holdings – Red-chip IPO;
• ATAL Engineering Group – Red-chip IPO;
• BGI Genomics – A-share IPO;
• Allmed Medical Products – A-share IPO;
• Guangdong Jushen Logistics – A-share IPO;
• Guangdong Kingstrong Technology – A-share IPO;
• Wens Foodstuff Group – absorption merger with Guangdong Dahuanong Animal Health Products and overall listing;
• Wens Foodstuff Group – issuance of corporate bonds and US dollar-denominated bonds;
• Tianma Microelectronics – material asset restructuring;
• SDIC Capital – material asset restructuring and overall listing of SDIC Securities;
• GCI Science & Technology – material asset restructuring;
• TCL Technology Group – non-public Offering (private placement);
• NARI Technology – non-public offering (private placement);
• RayNeo (subsidiary of TCL Electronics Holdings) – financing; and
• Hainan Development Holdings Nanhai – change of control transaction.